2016 CMHC Preliminary Program Agenda

Wednesday, October 5, 2016

On a mobile device? Drag the schedule to the right to view all the event details.

Boston 2016

Wednesday, October 5, 2016 – CMHC General Sessions

Print the Schedule Download Brochure

11:00 am – 12:00 pm

CME Workshop
Capital – What Healthcare Professionals Need to Know About Money

David Joyce MD, MBA

12:15 – 1:30 pm

Lunch Symposium (non-CME)
Insights on Repatha® (evolocumab): A Clinical Perspective
Sponsored by Amgen, Inc.

Yehuda Handelsman, MD, FACP, FACE, FNLA

1:30 – 2:30 pm

CME Workshop
Leadership and Management for Healthcare Professionals

Paul A. Gurny, MBA, MS

2:45 – 4:00 pm
Pre-Registration Required

CME Workshop
A Wolf in Sheep's Clothing: Diagnostic and Treatment Challenges of Rare Lipid Disorders
Endorsed by the FH Foundation

James A. Underberg, MD;
Allison Jamison

4:00 – 4:10 pm

OPENING SESSIONS

Christie M. Ballantyne, MD; Robert H. Eckel, MD

4:10 – 5:00 pm

Keynote Session
Intravascular Ultrasound Insights into the Regression and Progression of Coronary Atherosclerosis

Steven E. Nissen, MD, MACC

6:00 – 7:00 pm

Non-CME Dinner Reception
Examining Options to Go Further in the Treatment of Adults with T2DM
Sponsored by Janssen Pharmaceuticals, Inc.

Cres Miranda, MD

7:00 – 8:30 pm
Pre-Registration Required

CME Symposium
Nutritional Interventions in Clinical Practice: What Every Clinician Needs to Know

Stephen Devries, MD, FACC

Thursday, October 6, 2016 – CMHC General Sessions

6:30 – 8:00 am
Pre-Registration Required

CME Breakfast Symposium A
The New Face of Lipid Management for Patients with Hypercholesterolemia and Statin Intolerance

Chairperson: Steven E. Nissen, MD, MACC
Presenters: Michael H. Davidson, MD; Robert H. Eckel, MD

6:30 – 8:00 am
Pre-Registration Required

CME Breakfast Symposium B
Handling the Challenging Cases: Identifying and Managing Hyponatremia in Heart Failure Patients

Michael Emmett, MD, MACP; Stephen Gottlieb, MD

Session I. DYSLIPIDEMIA, ATHEROSCLEROSIS AND CARDIOVASCULAR DISEASE RISK REDUCTION

8:00 – 8:10 am

Opening Remarks

Christie M. Ballantyne, MD

8:10 – 9:15 am

Late-Breaking Clinical Trials and FDA Update

Moderator:
Christie M. Ballantyne, MD
Panelists:
Deepak L. Bhatt, MD, MPH; Robert H. Eckel, MD;
Keith C. Ferdinand, MD; Jay S. Skyler, MD

9:15 – 9:45 am

Keynote Session
Triglycerides on the Rise: Should We Swap Seats on the Seesaw?

Peter Libby, MD

9:45 – 10:45 am
Exhibit Hall

Morning Break/Meet the Experts

10:45 – 11:15 am

Lipid-Modifying Therapies 2016: Opportunities and Challenges

Christie M. Ballantyne, MD

11:15 am – 12:15 pm

Challenging Lipid Cases, Panel Discussion, and Q&A

Moderator:
Christie M. Ballantyne, MD
Panelists: Robert H. Eckel, MD; Pam Morris, MD

12:15 – 1:45 pm
Pre-Registration Required

CME Lunch Symposium A
New Developments in Insulin Therapy: Expert Insights in Individualizing Treatment

Chairperson
Bernard Zinman, MD
Presenters:
Anne L. Peters, MD; Athena Philis-Tsimikas, MD; Jean-François Yale, MD

12:15 – 1:45 pm
Pre-Registration Required

CME Lunch Symposium B
Patient-focused LDL-C Management and Risk Reduction in Clinical Practice: The Utility of PCSK9 Inhibitors

Chairperson:
Christie M. Ballantyne, MD
Presenters:
Henry A. Ginsberg, MD; Michael J. Koren, MD; James A. Underberg, MD

1:45 – 2:30 pm

Cardiometabolic Challenges: Cases from Clinical Practice

Moderator: Christie M. Ballantyne, MD
Panelists:
George L. Bakris, MD; Deepak L. Bhatt, MD, MPH; Robert H. Eckel, MD;
Jay S. Skyler, MD

2:30 – 3:30 pm
Exhibit Hall

Afternoon Break/Meet the Experts

3:30 – 4:25 pm

The Latest in Antithrombotic Therapy: The Experts Take Sides

Moderator: Deepak L. Bhatt, MD, MPH
Panelist: Kenneth Mahaffey, MD Gregg W. Stone, MD

4:25 – 4:30 pm

Closing Remarks

Christie M. Ballantyne, MD

4:30 – 5:30 pm
Exhibit Hall

Welcome Reception/Exhibitor Showcase/Meet the Experts

5:30 pm
Exhibit Hall

Exhibitor Showcase Closes

5:30 – 6:30 pm

Non-CME Session A
Widespread Lack or Loss of Adipose Tissue and Metabolic Abnormalities – Could it Be Generalized Lipodystrophy?
Sponsored by Aegerion Pharmaceuticals, Inc.

Tamer Yacoub, MD

5:30 – 6:30 pm

Non-CME Session B
Pure EPA: Mechanism and Clinical Data
Sponsored by Amarin Pharma, Inc.

Matthew Budoff, MD

6:30 – 8:00 pm
Pre-Registration Required

CME Dinner Symposium
Managing Inflammation: A Novel Approach for Secondary Prevention of CVD Risks

Chairperson
Christie M. Ballantyne, MD
Presenters:
Peter Libby, MD ; Paul M. Ridker, MD

Friday, October 7, 2016 – CMHC General Sessions

6:30 – 7:45 am
Pre-Registration Required

CME Breakfast Symposium
Consider the Comorbidities and Clinical Challenges: Individualizing Stroke Prevention Therapy in Complex Patients with NVAF

Chairperson
Deepak L. Bhatt, MD, MPH
Presenters:
Elaine M. Hylek, MD, MPH; Christian T. Ruff, MD, MPH

Session II: HYPERTENSION, CARDIO-RENAL, HEART FAILURE

8:00 – 8:05 am

Opening Remarks

George L. Bakris, MD

8:05 – 8:40 am

Keynote Session
Update and Clinical Implications of the SPRINT trial

Suzanne Oparil, MD

8:40 – 9:05 am

Patient Case Discussion: SPRINT Slowly to Lower BP in Everyone

Moderator:
George L. Bakris, MD
Panelists:
Paul M. Muntner, PhD; Clyde W. Yancy, MD

9:05 – 9:30 am

Heart Failure in the Context of SPRINT: What has changed?

Clyde W. Yancy, MD

9:30 – 10:30 am
Exhibit Hall

Morning Break/Meet the Experts

10:30 – 10:50 am

SGLT2s: Should They Be Second Line Therapy?

George L. Bakris, MD

10:50 – 11:30 am

Panel Discussion and Q&A: Case Consults in Hypertension

Moderator:
George L. Bakris, MD
Panelists:
Keith C. Ferdinand, MD; Suzanne Oparil, MD; Clyde W. Yancy, MD

11:30 am – 1:00 pm
Pre-Registration Required

CME Lunch Symposium A
Evolving Therapeutic Paradigms for the Management of Hyperkalemia

Chairperson
George L. Bakris, MD
Presenters: Rajiv Agarwal, MD; JoAnn Lindenfeld, MDRobert Toto, MD;

11:30 am – 1:00 pm
Pre-Registration Required

CME Lunch Symposium B
New Frontiers in the Prevention and Management of Heart Failure

Chairperson
Clyde W. Yancy, MD
Presenters: Javed Butler, MD, MPH; Keith C. Ferdinand, MD; Clyde W. Yancy, MD

Session III. DIABETES MANAGEMENT

1:00 – 1:10 pm

Opening Remarks

Jay S. Skyler, MD

1:10 – 1:45 pm

Keynote Session
The Gut Microbiome as a Modifier of Insulin Resistance and Metabolic Syndrome

C. Ronald Kahn, MD

1:45 – 2:15 pm

Update on Cardiovascular Outcome Trials in Diabetes

Jay S. Skyler, MD

2:15 – 3:15 pm
Exhibit Hall

Afternoon Break/Meet the Experts

3:15 – 3:45 pm

Insulin Therapy Options: What's in Store for 2017?

Irl Hirsch, MD

3:45 – 4:10 pm

Non-insulin Therapy Options: A Look Ahead for 2017

Robert E. Ratner, MD

4:10 – 4:55 pm

Panel Discussion and Q&A: Expert Cases in Diabetes

Moderator:
Jay S. Skyler, MD
Panelists:
George L. Bakris, MD; Robert H. Eckel, MD; Irl Hirsch, MD; Robert E. Ratner, MD

4:55 – 5:25 pm

Implications of Recent Trials on Management of Diabetes: Should the Algorithms be Changed?

Moderator:
Jay S. Skyler, MD
Panelists:
Christie Ballantyne, MD; George L. Bakris, MD; Robert H. Eckel, MD;
Irl Hirsch, MD; Robert E. Ratner, MD

5:25 – 5:30 pm

Closing Remarks

Jay S. Skyler, MD

5:30 – 6:30 pm

Networking CMHC Reception/Exhibitor Showcase/Meet the Experts

6:30 pm
Exhibit Hall

Exhibitor Showcase Closes

Saturday, October 8, 2016 – CMHC General Sessions

6:30 – 8:00 am
Pre-Registration Required

CME Breakfast Symposium
Combining GLP-1RAs with Insulin to Improve Glucose Control.

Chairperson
Jay S. Skyler, MD
Presenters:
Robert E. Ratner, MD; Robert H. Eckel, MD; Julio Rosenstock, MD

Session IV. OBESITY, LIFESTYLE MANAGEMENT AND CARDIOVASCULAR DISEASE

8:05 – 8:10 am

Opening Remarks

Robert H. Eckel, MD

8:10 – 9:00 am

Keynote Session
Obesity Fat Distribution And Cardiovascular Risk

Subodh Verma, MD, PhD

9:00 – 9:50 am

A Dialogue Between the Experts: the Newest Evidence on Metabolic Surgery

Lee Kaplan, MD; Francesco Rubino, MD

9:50 – 10:15 am
Grand Foyer Ballroom

Morning Break/Meet the Experts

10:15 – 10:50 am

Lifestyle, Behavioral and Pharmacological Approaches to Obesity Management

Caroline Apovian, MD

10:50 – 11:35 am

Panel Discussion and Q&A: Case Consults on Lifestyle and Obesity Management of CVD

Moderator:
Robert H. Eckel, MD
Panelists: Caroline Apovian, MD; Lee Kaplan, MD; Francesco Rubino, MD

11:35 – 11:45 am

Closing Remarks

Robert H. Eckel, MD

Note: Agenda & Faculty are subject to change.

Register Now